According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
French Health Minister Olivier Veran has said this morning that half a million appointments were available throughout France to get vaccinated. He add...
Read More
Covid-19- Two more people have died from coronavirus in the Alpes Maritimes bringing the total number in the department who’ve lost their lives to th...
Read More
Health Pass- The French Constitutional Council will announce on the 5th of August the exact details of the government’s health pass regulations follow...
Read More
In Corsica, the Prefect of the Haute-Corse department has announced that establishments open to the public such as bars and restaurants will have to c...
Read More
